我与 Moderna $MRNA CEO Stéphane Bancel 交谈,讨论了 intismeran 以及这款癌症疫苗和他所领导的这家生物技术公司的下一步。 “我们知道这项 III 期研究的临床影响是真实且巨大的,所以我们必须积极进取。我们需要探索其生物学机制。会有一些风险,因为它不会在所有情况下都奏效。” 阅读问答: https://www.statnews.com/2026/10/26/moderna-ceo-stephane-bancel-interview-cancer-vaccine-intismeran/ #ESMO26
I spoke with Moderna $MRNA CEO Stéphane Bancel about intismeran and what's next for the cancer vaccine and the biotech he runs.
"We know the clinical impact in the Phase 3 study is real and big, so we need to go and be aggressive. We need to explore the biology. There will be some risk, because it’s not going to work everywhere."
Read the Q&A:
https://www.statnews.com/2026/10/26/moderna-ceo-stephane-bancel-interview-cancer-vaccine-intismeran/ #ESMO26
来源:Adam Feuerstein ✡️ · x.com